BACKGROUND: Tumors of the fourth ventricle are frequently treated pathologies in pediatric neurosurgery. Data regarding predictors for permanent neurological deficits, long-term functional outcomes, cerebellar mutism (CM), the extent of resection (EOR), and oncological outcomes are scarce. We attempt to contribute to this topic with an analysis of our institutional cohort. METHODS: A retrospective single-center study of patients aged ≤ 19 years who underwent primary surgical resection of a fourth ventricular tumor over a 15-year period (2006-2021). Predictors analyzed included age, gender, surgical approach, anatomical pattern, tumor grade, EOR, tumor volume, and others as appropriate. RESULTS: One hundred six patients were included (64 males, mean age 7.3 years). The rate of permanent neurological deficit was 24.2%; lateral tumor extension (p = 0.036) and tumor volume greater than 38 cm3 (p = 0.020) were significant predictors. The presence of a deficit was the only significant predictor of reduced (less than 90) Lansky score (p = 0.005). CM occurred in 20.8% of patients and was influenced by medulloblastoma histology (p = 0.011), lateral tumor extension (p = 0.017), and male gender (p = 0.021). No significant difference between the transvermian and telovelar approach in the development of CM was detected (p = 0.478). No significant predictor was found for the EOR. EOR was not found to be a significant predictor of overall survival for both low-grade and high-grade tumors; however, gross total resection (GTR) was protective against tumor recurrence compared to near-total or subtotal resection (p < 0.001). In addition, survival was found to be better in older patients (≥ 7.0 years, p = 0.019). CONCLUSION: The overall rate of postoperative complications remains high due to the eloquent localization. Older patients (> 7 years) have been found to have better outcomes and prognosis. Achieving GTR whenever feasible and safe has been shown to be critical for tumor recurrence. CM was more common in patients with medulloblastoma and in patients with tumors extending through the foramen of Luschka. The telovelar approach uses a safe and anatomically sparing corridor; however, it has not been associated with a lower incidence of CM and neurological sequelae in our series, showing that each case should be assessed on an individual basis.

Center for Pediatric Neuro Oncology University Hospital Motol 5 Úvalu 84 150 06 Prague 5 Prague Czech Republic

Department of Neurosurgery 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Neurosurgery and Neurooncology 1st Faculty of Medicine Charles University and Military University Hospital Prague Czech Republic

Department of Neurosurgery Charité Universitätsmedizin Berlin Berlin Germany

Department of Pathology and Molecular Medicine 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Pediatric Haematology and Oncology 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Radiology 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Zobrazit více v PubMed

Ashida R, Nazar N, Edwards R, Teo M (2021) Cerebellar mutism syndrome: an overview of the pathophysiology in relation to the cerebrocerebellar anatomy, risk factors, potential treatments, and outcomes. World Neurosurg 153:63–74. https://doi.org/10.1016/j.wneu.2021.06.065 PubMed DOI

Atallah A, Rady MR, Kamal HM, El-Mansy N, Alsawy MFM, Hegazy A, Zaghloul M (2019) Telovelar approach to pediatric fourth ventricle tumors: feasibility and outcome. Turk Neurosurg 29:497–505. https://doi.org/10.5137/1019-5149.Jtn.24078-18.3 PubMed DOI

Beneš V, Zápotocký M, Libý P, Táborský J, Blažková J, Blažková J, Sumerauer D, Mišove A, Perníková I, Kynčl M et al (2022) Survival and functional outcomes in paediatric thalamic and thalamopeduncular low grade gliomas. Acta Neurochir 164:1459–1472. https://doi.org/10.1007/s00701-021-05106-5 PubMed DOI

Catsman-Berrevoets CE, Van Dongen HR, Mulder PGH, Y Geuze DP, Paquier PF, Lequin MH (1999) Tumour type and size are high risk factors for the syndrome of “cerebellar” mutism and subsequent dysarthria. J Neurol Neurosurg Psychiatry 67:755–757. https://doi.org/10.1136/jnnp.67.6.755 PubMed DOI

Dandy WE (1932) The practice of surgery. The Brain. Hagerstwon, MD: WF Prior 12

Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR et al (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725–1731. https://doi.org/10.1056/nejm199306173282401 PubMed DOI

Eissa E (2017) The role of telovelar approach in fourth ventricular surgery: a new perspective. Turk Neurosurg. https://doi.org/10.5137/1019-5149.jtn.21209-17.1 DOI

El-Bahy K (2005) Telovelar approach to the fourth ventricle: operative findings and results in 16 cases. Acta Neurochir 147:137–142. https://doi.org/10.1007/s00701-004-0407-0 PubMed DOI

Fabozzi F, Margoni S, Andreozzi B, Musci MS, Del Baldo G, Boccuto L, Mastronuzzi A, Carai A (2022) Cerebellar mutism syndrome: from pathophysiology to rehabilitation. Front Cell Dev Biol 10:1082947. https://doi.org/10.3389/fcell.2022.1082947 PubMed DOI PMC

Ferguson SD, Levine NB, Suki D, Tsung AJ, Lang FF, Sawaya R, Weinberg JS, McCutcheon IE (2018) The surgical treatment of tumors of the fourth ventricle: a single-institution experience. J Neurosurg 128:339–351. https://doi.org/10.3171/2016.11.jns161167 PubMed DOI

Grønbæk JK, Wibroe M, Toescu S, Frič R, Thomsen BL, Møller LN, Grillner P, Gustavsson B, Mallucci C, Aquilina K et al (2021) Postoperative speech impairment and surgical approach to posterior fossa tumours in children: a prospective European multicentre cohort study. Lancet Child Adolesc Health 5:814–824. https://doi.org/10.1016/s2352-4642(21)00274-1 PubMed DOI

Gudrunardottir T, Morgan AT, Lux AL, Walker DA, Walsh KS, Wells EM, Wisoff JH, Juhler M, Schmahmann JD, Keating RF et al (2016) Consensus paper on post-operative pediatric cerebellar mutism syndrome: the Iceland Delphi results. Child’s Nerv Syst 32:1195–1203. https://doi.org/10.1007/s00381-016-3093-3 DOI

Jabarkheel R, Amayiri N, Yecies D, Huang Y, Toescu S, Nobre L, Mabbott DJ, Sudhakar SV, Malik P, Laughlin S et al (2020) Molecular correlates of cerebellar mutism syndrome in medulloblastoma. Neuro Oncol 22:290–297. https://doi.org/10.1093/neuonc/noz158 PubMed DOI

Jaju A, Yeom KW, Ryan ME (2022) MR imaging of pediatric brain tumors. Diagnostics 12:961. https://doi.org/10.3390/diagnostics12040961 PubMed DOI PMC

Jiang T, Zhang Y, Wang J, Du J, Ma Z, Li C, Liu R, Zhang Y (2016) Impact of tumor location and fourth ventricle infiltration in medulloblastoma. Acta Neurochir 158:1187–1195. https://doi.org/10.1007/s00701-016-2779-3 PubMed DOI

Kellogg JX, Piatt JH Jr (1997) Resection of fourth ventricle tumors without splitting the vermis: the cerebellomedullary fissure approach. Pediatr Neurosurg 27:28–33. https://doi.org/10.1159/000121221 PubMed DOI

Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304–1305. https://doi.org/10.1161/01.str.27.8.1304 PubMed DOI

Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller DR (1987) The measurement of performance in childhood cancer patients. Cancer 60:1651–1656. https://doi.org/10.1002/1097-0142 PubMed DOI

Louis DN, Wesseling P, Aldape K, Brat DJ, Capper D, Cree IA, Eberhart C, Figarella-Branger D, Fouladi M, Fuller GN et al (2020) cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol 30:844–856. https://doi.org/10.1111/bpa.12832 PubMed DOI PMC

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106 PubMed DOI PMC

Maloumeh EN, Khoshnoud RJ, Ebrahimzadeh K, Tavassol HH, Salari S, Mousavinejad A, Kargari A, Samadian M, Rezaei O (2021) Surgical management of the fourth ventricular tumors using telovelar approach and the role of neuroendoscopy: post-operative outcome and long-term results in a series of 52 cases. Clin Neurol Neurosurg 201:106419. https://doi.org/10.1016/j.clineuro.2020.106419 PubMed DOI

Mariën P, De Smet HJ, Wijgerde E, Verhoeven J, Crols R, De Deyn PP (2013) Posterior fossa syndrome in adults: a new case and comprehensive survey of the literature. Cortex 49:284–300. https://doi.org/10.1016/j.cortex.2011.06.018 PubMed DOI

Matsushima T, Rhoton AL Jr, Lenkey C (1982) Microsurgery of the fourth ventricle: part 1. Microsurgical anatomy. Neurosurgery 11:631–667. https://doi.org/10.1227/00006123-198211000-00008 PubMed DOI

Morris EB, Phillips NS, Laningham FH, Patay Z, Gajjar A, Wallace D, Boop F, Sanford R, Ness KK, Ogg RJ (2009) Proximal dentatothalamocortical tract involvement in posterior fossa syndrome. Brain 132:3087–3095. https://doi.org/10.1093/brain/awp241 PubMed DOI PMC

Morrissy AS, Cavalli FMG, Remke M, Ramaswamy V, Shih DJH, Holgado BL, Farooq H, Donovan LK, Garzia L, Agnihotri S et al (2017) Spatial heterogeneity in medulloblastoma. Nat Genet 49:780–788. https://doi.org/10.1038/ng.3838 PubMed DOI PMC

Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P et al (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29:1408–1414. https://doi.org/10.1200/jco.2009.27.4324 PubMed DOI

Onorini N, Spennato P, Orlando V, Savoia F, Calì C, Russo C, De Martino L, de Santi MS, Mirone G, Ruggiero C et al (2022) The clinical and prognostic impact of the choice of surgical approach to fourth ventricular tumors in a single-center, single-surgeon cohort of 92 consecutive pediatric patients. Front Oncol 12:821738. https://doi.org/10.3389/fonc.2022.821738 PubMed DOI PMC

Pettersson SD, Kitlinski M, Miękisiak G, Ali S, Krakowiak M, Szmuda T (2022) Risk factors for postoperative cerebellar mutism syndrome in pediatric patients: a systematic review and meta-analysis. J Neurosurg: Pediatr 29:467–475. https://doi.org/10.3171/2021.11.peds21445 PubMed DOI

Pols SYCV, Van Veelen MLC, Aarsen FK, Gonzalez Candel A, Catsman-Berrevoets CE (2017) Risk factors for development of postoperative cerebellar mutism syndrome in children after medulloblastoma surgery. J Neurosurg: Pediatr 20:35–41. https://doi.org/10.3171/2017.2.peds16605 PubMed DOI

Rajesh BJ, Rao BRM, Menon G, Abraham M, Easwer HV, Nair S (2007) Telovelar approach: technical issues for large fourth ventricle tumors. Child’s Nerv Syst 23:555–558. https://doi.org/10.1007/s00381-006-0295-0 DOI

Resende LL, Alves CSAPF (2021) Imaging of brain tumors in children: the basics—a narrative review. Transl Pediatr 10:1138–1168. https://doi.org/10.21037/tp-20-285 PubMed DOI PMC

Tamburrini G, Frassanito P, Chieffo D, Massimi L, Caldarelli M, Di Rocco C (2015) Cerebellar mutism. Child’s Nerv Syst 31:1841–1851. https://doi.org/10.1007/s00381-015-2803-6 DOI

Thomale UW, Driever PH (2013) Inconsistent terminology for cerebellar mutism. Childs Nerv Syst 29:717–718. https://doi.org/10.1007/s00381-013-2074-z PubMed DOI

Toescu SM, Samarth G, Layard Horsfall H, Issitt R, Margetts B, Phipps KP, Jeelani NU, Thompson DNP, Aquilina K (2020) Fourth ventricle tumors in children: complications and influence of surgical approach. J Neurosurg Pediatr 27:52–61. https://doi.org/10.3171/2020.6.Peds2089 PubMed DOI

Tomasello F, Conti A, Cardali S, La Torre D, Angileri FF (2015) Telovelar approach to fourth ventricle tumors: highlights and limitations. World Neurosurg 83:1141–1147. https://doi.org/10.1016/j.wneu.2015.01.039 PubMed DOI

Yang W, Cai Y, Chen J, Yang P, Ying Z, Liang Y, Ling M, Zhu K, Sun H, Ji Y et al (2023) Epidemiological characteristics, clinical presentations, and prognoses of pediatric brain tumors: experiences of national center for children’s health. Front Oncol 13:1067858. https://doi.org/10.3389/fonc.2023.1067858 PubMed DOI PMC

Yaşargil MG, Abdulrauf SI (2008) Surgery of intraventricular tumors. Neurosurgery 62:1029–1040. https://doi.org/10.1227/01.neu.0000333768.12951.9a . (discussion 1040–1021) PubMed DOI

Zaheer SN, Wood M (2010) Experiences with the telovelar approach to fourth ventricular tumors in children. Pediatr Neurosurg 46:340–343. https://doi.org/10.1159/000321539 PubMed DOI

Prognostic factors of thalamic and thalamopeduncular low-grade gliomas in children: A systematic review and recommendations for surgical management